Source: Clinical and Experimental Pharmacology and Physiology. Unidades: EEFERP, FORP, FMRP
Subjects: DEGRANULAÇÃO CELULAR, INFLAMAÇÃO, INTERLEUCINA 6, EXERCÍCIO FÍSICO
ABNT
PINTO, Ana Paula et al. Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage. Clinical and Experimental Pharmacology and Physiology, v. 49, n. 8, p. 893-902, 2022Tradução . . Disponível em: https://doi.org/10.1111/1440-1681.13677. Acesso em: 16 nov. 2024.APA
Pinto, A. P., Rocha, A. L. da, Marafon, B. B., Nogueira, J. E., Branco, L. G. de S., Pauli, J. R., et al. (2022). Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage. Clinical and Experimental Pharmacology and Physiology, 49( 8), 893-902. doi:10.1111/1440-1681.13677NLM
Pinto AP, Rocha AL da, Marafon BB, Nogueira JE, Branco LG de S, Pauli JR, Moura LP de, Cintra DE, Ropelle ER, Silva ASR da. Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage [Internet]. Clinical and Experimental Pharmacology and Physiology. 2022 ; 49( 8): 893-902.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/1440-1681.13677Vancouver
Pinto AP, Rocha AL da, Marafon BB, Nogueira JE, Branco LG de S, Pauli JR, Moura LP de, Cintra DE, Ropelle ER, Silva ASR da. Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage [Internet]. Clinical and Experimental Pharmacology and Physiology. 2022 ; 49( 8): 893-902.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/1440-1681.13677